FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313556827> ?p ?o ?g. }

• W4313556827 abstract "Introduction: The transparency of data on the value chain of medicines is crucial for the study and monitoring of the pharmaceutical system. These data may impact medicine pricing negotiations, contribute to patient access to pharmaceutical products, and strengthen health systems. Objective: This study analyzed the national strategies to ensure the transparency of data from medicine cost development to marketing in Argentina, Brazil, and Colombia. Method: A descriptive study was carried out by searching databases, reports, documents, and scientific articles published between January and August 2022 related to rules on transparency and databases, including 1) marketing authorization; 2) pricing; 3) intellectual property; 4) clinical trials; 5) research and development (R&D); and 6) health technology assessment (HTA) of selected biopharmaceuticals. Results: Transparency data, rules, and information are not uniform. The infostructures (organizational capacity for collecting and distributing information) regarding the pharmaceutical value chain in these three countries face limitations in appropriate measures to publicly share data and evidence, including pre-clinical data, clinical data, and costs. None of the countries require transparency about data on research and development costs. All three countries present similar publicization of data on marketing authorization and intellectual property, with some differences. The significant limitations in Argentina include the absence of formal price regulation and data on the volume of medicine purchased and respective amounts paid. Among the three countries, Brazil showed a higher degree of information transparency, perhaps due to the legal regulation that guarantees citizens access to information of public interest. Brazil also stands out in terms of the public availability of HTA reports and pricing, in addition to the highest volume of information. In contrast, Colombia has in place a decree that allows 5 years of trial data exclusivity for new medicines, an act contrary to data transparency. Despite the different stages of transparency, no country has evidenced a robust use of these data in public policy decision-making. Conclusion: The results reinforce the presence of information asymmetry between stakeholders, data fragmentation, data gaps and overlap, and difficulty in comparing available data across the three countries and the use of these data nationally to produce evidence." @default.
• W4313556827 created "2023-01-06" @default.
• W4313556827 creator A5021881232 @default.
• W4313556827 creator A5034636338 @default.
• W4313556827 creator A5048589634 @default.
• W4313556827 creator A5062095765 @default.
• W4313556827 creator A5063201869 @default.
• W4313556827 creator A5073243317 @default.
• W4313556827 date "2023-01-05" @default.
• W4313556827 modified "2023-10-14" @default.
• W4313556827 title "Transparency of data on the value chain of medicines in Argentina, Brazil, and Colombia" @default.
• W4313556827 cites W2038673349 @default.
• W4313556827 cites W2347058832 @default.
• W4313556827 cites W2610334677 @default.
• W4313556827 cites W2884518941 @default.
• W4313556827 cites W3136775058 @default.
• W4313556827 cites W3152157300 @default.
• W4313556827 cites W4200293789 @default.
• W4313556827 cites W4205646583 @default.
• W4313556827 cites W4212984242 @default.
• W4313556827 doi "https://doi.org/10.3389/fphar.2022.1063300" @default.
• W4313556827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36686702" @default.
• W4313556827 hasPublicationYear "2023" @default.
• W4313556827 type Work @default.
• W4313556827 citedByCount "0" @default.
• W4313556827 crossrefType "journal-article" @default.
• W4313556827 hasAuthorship W4313556827A5021881232 @default.
• W4313556827 hasAuthorship W4313556827A5034636338 @default.
• W4313556827 hasAuthorship W4313556827A5048589634 @default.
• W4313556827 hasAuthorship W4313556827A5062095765 @default.
• W4313556827 hasAuthorship W4313556827A5063201869 @default.
• W4313556827 hasAuthorship W4313556827A5073243317 @default.
• W4313556827 hasBestOaLocation W43135568271 @default.
• W4313556827 hasConcept C121955636 @default.
• W4313556827 hasConcept C138816342 @default.
• W4313556827 hasConcept C144133560 @default.
• W4313556827 hasConcept C159110408 @default.
• W4313556827 hasConcept C162853370 @default.
• W4313556827 hasConcept C17744445 @default.
• W4313556827 hasConcept C199539241 @default.
• W4313556827 hasConcept C199776023 @default.
• W4313556827 hasConcept C2777424817 @default.
• W4313556827 hasConcept C2777589142 @default.
• W4313556827 hasConcept C2780233690 @default.
• W4313556827 hasConcept C3019492093 @default.
• W4313556827 hasConcept C34974158 @default.
• W4313556827 hasConcept C38652104 @default.
• W4313556827 hasConcept C41008148 @default.
• W4313556827 hasConcept C60644358 @default.
• W4313556827 hasConcept C71924100 @default.
• W4313556827 hasConcept C86803240 @default.
• W4313556827 hasConceptScore W4313556827C121955636 @default.
• W4313556827 hasConceptScore W4313556827C138816342 @default.
• W4313556827 hasConceptScore W4313556827C144133560 @default.
• W4313556827 hasConceptScore W4313556827C159110408 @default.
• W4313556827 hasConceptScore W4313556827C162853370 @default.
• W4313556827 hasConceptScore W4313556827C17744445 @default.
• W4313556827 hasConceptScore W4313556827C199539241 @default.
• W4313556827 hasConceptScore W4313556827C199776023 @default.
• W4313556827 hasConceptScore W4313556827C2777424817 @default.
• W4313556827 hasConceptScore W4313556827C2777589142 @default.
• W4313556827 hasConceptScore W4313556827C2780233690 @default.
• W4313556827 hasConceptScore W4313556827C3019492093 @default.
• W4313556827 hasConceptScore W4313556827C34974158 @default.
• W4313556827 hasConceptScore W4313556827C38652104 @default.
• W4313556827 hasConceptScore W4313556827C41008148 @default.
• W4313556827 hasConceptScore W4313556827C60644358 @default.
• W4313556827 hasConceptScore W4313556827C71924100 @default.
• W4313556827 hasConceptScore W4313556827C86803240 @default.
• W4313556827 hasLocation W43135568271 @default.
• W4313556827 hasLocation W43135568272 @default.
• W4313556827 hasLocation W43135568273 @default.
• W4313556827 hasOpenAccess W4313556827 @default.
• W4313556827 hasPrimaryLocation W43135568271 @default.
• W4313556827 hasRelatedWork W1514514431 @default.
• W4313556827 hasRelatedWork W2606616691 @default.
• W4313556827 hasRelatedWork W2740154143 @default.
• W4313556827 hasRelatedWork W2775678066 @default.
• W4313556827 hasRelatedWork W2797750655 @default.
• W4313556827 hasRelatedWork W3146819096 @default.
• W4313556827 hasRelatedWork W3146920234 @default.
• W4313556827 hasRelatedWork W4283793902 @default.
• W4313556827 hasRelatedWork W4313556827 @default.
• W4313556827 hasRelatedWork W3082716300 @default.
• W4313556827 hasVolume "13" @default.
• W4313556827 isParatext "false" @default.
• W4313556827 isRetracted "false" @default.
• W4313556827 workType "article" @default.